Derek Hicks, EVP, Chief Business Officer at Intellia Therapeutics, holds 59.88K shares in Intellia Therapeutics (Ticker: NTLA). Most recently, Derek Hicks Sold $6,502 shares of Intellia Therapeutics on Jan 07, 2025 for an estimated value of 79.19K.
What is the percentage of profitable transactions made by Derek Hicks?
The percentage of profitable transactions made by Derek Hicks is 100%.
What is the average return per transaction made by Derek Hicks?
The average return per transaction made by Derek Hicks is 33.50%.
What stocks does Derek Hicks hold?
Derek Hicks holds: NTLA stocks.
What was Derek Hicks’s latest transaction?
Derek Hicks latest transaction was an Informative Sell of $79.19K.
What was Derek Hicks's most profitable transaction?
Derek Hicks’s most profitable transaction was an Informative Sell of NTLA stock on January 5, 2024. The return on the trade was 57.60%.
What is Derek Hicks's role in Intellia Therapeutics?
Derek Hicks's role in Intellia Therapeutics is EVP, Chief Business Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.